Inj Dexmedetomidine 100mcg per ml 2 ml inj,Ketamine HCL 50 mg per ml 2ml inj,Thiopentone inj of hal
Indian Army
POONCH, JAMMU & KASHMIR
Bid Publish Date
26-Jun-2025, 11:25 am
Bid End Date
17-Jul-2025, 2:00 pm
Value
₹26,67,986
Location
Progress
RAQuantity
32130
Category
Rocuronium 10 mgml Vail of 10 ml Inj
Bid Type
Two Packet Bid
Indian Army has released a public tender for Rocuronium 10 mgml Vail of 10 ml Inj, Ketamine HCl 50 mgml 2 ml Inj, Thiopentone Inj of 0dot5 g without water for Inj, Bupivacaine HCl 5 mgml 20 ml Inj, Bupivacaine HCl 5 mgml Heavy 4 ml Inj, Lignocaine HCl 2percentwithout Adrenaline, Lignocaine HCl 2percent with Adrenalin, Inj Diclofenac 75 mgml 1 ml, Atropine Sulphate 0dot6 mg 1 ml Inj, Paracetamol with Cysteine HCl monohydrate infusion 1000 mg100 ml, Paracetamol 10 mgml infusion in 100 ml bottle, Fentanyl Citrate 50 mcgml 2 ml Inj, Fentanyl 50 mcgml10 ml Inj, Morphine 15 mg 1 ml Inj, Pethedine 50 mg 1 ml Inj, Ketorolac 30 mgml 1ml Inj, Betamethasone 4 mg 1ml Inj, Adrenaline Tartrate 1colon 1000 1 ml Inj, Dexamethasone Sodium Phosphate 4dot4, Levetiracetam 100 mgml vial of 5 ml Inj, Diazepam 10 mg 2 ml Inj, Fosphenytoin 75 mgml 2ml Inj, Sodium Valproate 100 mgml Inj, Inj Amikacin IP 100 mg2 ml Vial, Artesunate 60 mg Inj, Artemether 80 mgml 1 ml Inj, Inj Ceftriaxone 500 mg Vial, Ceftriaxone 1000 mg plus Sulbactum 500 mg Inj Vial, Inj Cefotaxime Sodium 1000 mg plus Sulbactam 500 mg Inj Vial, Methotrexate Sodium 50mg 2 ml Inj, Iron sucrose complex 20 mg in 5ml for Inj, Tranexamic Acid 500 mg5ml Inj, Phytomenadione 1 mg0dot5 ml Vitamin K Inj, Mannitol 20percent bottle of 100ml, Diltiazem 5mgml Inj, Adenosine 3 mgml 2 ml Inj, Amiodarone HCl 150 mg 3 ml Inj, Metoprolol 1 mgml 5 ml Inj, Vasopressin 20 unitsml1ml Inj, Dopamine HCl 40 mgml 5ml Inj, Dobutamine HCl 250 mg 5 ml Inj, Enoxaparin 40 mg0dot4ml Inj, Labetalol HCl 5mgml 4ml Inj, Triamcinolone Acetate 10 mgml Inj, Frusemide 20 mg 2 ml Inj, Mannitol 20percent Inj bottle of 350 ml, Human Albumin 20percent in bott of 100ml Inj, Metoclopramide HCl 5mgml 2ml Inj, Dicyclomine HCl 20 mg Inj, Hydroxyprogesterone Caproate 500 mg2 ml 2 ml Inj, Isoxsuprine HCl 5mgml amp of 2 ml, Methylergometrine maleate 0dot2mg 1 ml Inj, Oxytocin 5 units per 1dot0 ml amp Inj, Magnesium sulphate 50percent wv Inj, Human Chorionic Gonadotrophin 2000 IU HCG Inj, Glycopyrrolate 0dot2 mgml 1ml Inj, Neostigmine 0dot5 mg1 ml Inj, Succinylchloline Chloride 50 mgml 2 ml Inj, Vecuronium Bromide 4mgml 1 ml Inj, Etophylline BP 84dot7 mg and Theophylline IP, Dextrose 50percent 25 ml Inj, Dextrose Inj 25percent 25 ml Inj, Meropenem 1 gm Inj, Multi Vit IV 2-10 ml with minimum constituents having Thiamine, Human Insulin Analogue Glargine Recombinant DNA origin, Amoxycillin 1g plus Clavulanic Acid 200 mg, Amikacin Sulphate 250 mg2 ml Inj, Cefotaxime Sodium 1gm Inj, Cefoperazone Sodium 1gm sulbactum, Ceftriaxone 1 gm Monocef Inj, Gentamycin sulphate Inj IMIV 40mgml 2 ml Inj, Piperacillin 4 gm plusTazobactam 500 mg lyophilized Inj, Meropenem 500 mg Inj, Linezolid 2 mgml 300 ml Inj, Inj Thiamine 100 mgml 2 ml Amp, Tetanus Toxoid purified absorbedr, Dexmedetomidine 100 mcg ml vial of 50 ml Inj, Pralidoxime 500 mg20 ml Inj, Drotaverin 40mg2ml Injection, Valethamate bromide 2 ml Inj, Lignocaine 2percent PF Preservation Free Inj, Lignocaine hcl Sol 2percent for IV use 30ml Inj, Tuberculin PPD Inj, Chloecalcifero Vitamin D3 6 Lac Inj, Menotropin for Sodium Chloride 75 IU HMG Inj in NASHIK, MAHARASHTRA. Quantity: 32130. Submission Deadline: 17-07-2025 14: 00: 00. Download documents and apply online.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
POONCH, JAMMU & KASHMIR
Indian Army
POONCH, JAMMU & KASHMIR
Indian Army
North Goa, GOA
Indian Army
Dg Armed Forces Medical Service
DARJEELING, WEST BENGAL
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Rocuronium 10 mgml Vail of 10 ml Inj | Rocuronium 10 mgml Vail of 10 ml Inj | 15 | vial | shakil.463n | 30 |
| 2 | Ketamine HCl 50 mgml 2 ml Inj | Ketamine HCl 50 mgml 2 ml Inj | 30 | amp | shakil.463n | 30 |
| 3 | Thiopentone Inj of 0dot5 g without water for Inj | Thiopentone Inj of 0dot5 g without water for Inj | 15 | vial | shakil.463n | 30 |
| 4 | Bupivacaine HCl 5 mgml 20 ml Inj | Bupivacaine HCl 5 mgml 20 ml Inj | 105 | vial | shakil.463n | 30 |
| 5 | Bupivacaine HCl 5 mgml Heavy 4 ml Inj | Bupivacaine HCl 5 mgml Heavy 4 ml Inj | 180 | vial | shakil.463n | 30 |
| 6 | Lignocaine HCl 2percentwithout Adrenaline | Lignocaine HCl 2percentwithout Adrenaline | 300 | vial | shakil.463n | 30 |
| 7 | Lignocaine HCl 2percent with Adrenalin | Lignocaine HCl 2percent with Adrenalin | 90 | vial | shakil.463n | 30 |
| 8 | Inj Diclofenac 75 mgml 1 ml | Inj Diclofenac 75 mgml 1 ml | 1,200 | amp | shakil.463n | 30 |
| 9 | Atropine Sulphate 0dot6 mg 1 ml Inj | Atropine Sulphate 0dot6 mg 1 ml Inj | 450 | amp | shakil.463n | 30 |
| 10 | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg100 ml | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg100 ml | 1,500 | bott | shakil.463n | 30 |
| 11 | Paracetamol 10 mgml infusion in 100 ml bottle | Paracetamol 10 mgml infusion in 100 ml bottle | 2,100 | bott | shakil.463n | 30 |
| 12 | Fentanyl Citrate 50 mcgml 2 ml Inj | Fentanyl Citrate 50 mcgml 2 ml Inj | 180 | amp | shakil.463n | 30 |
| 13 | Fentanyl 50 mcgml10 ml Inj | Fentanyl 50 mcgml10 ml Inj | 60 | amp | shakil.463n | 30 |
| 14 | Morphine 15 mg 1 ml Inj | Morphine 15 mg 1 ml Inj | 18 | amp | shakil.463n | 30 |
| 15 | Pethedine 50 mg 1 ml Inj | Pethedine 50 mg 1 ml Inj | 120 | amp | shakil.463n | 30 |
| 16 | Ketorolac 30 mgml 1ml Inj | Ketorolac 30 mgml 1ml Inj | 15 | amp | shakil.463n | 30 |
| 17 | Betamethasone 4 mg 1ml Inj | Betamethasone 4 mg 1ml Inj | 300 | amp | shakil.463n | 30 |
| 18 | Adrenaline Tartrate 1colon 1000 1 ml Inj | Adrenaline Tartrate 1colon 1000 1 ml Inj | 1,200 | amp | shakil.463n | 30 |
| 19 | Dexamethasone Sodium Phosphate 4dot4 | Dexamethasone Sodium Phosphate 4dot4 | 450 | amp | shakil.463n | 30 |
| 20 | Levetiracetam 100 mgml vial of 5 ml Inj | Levetiracetam 100 mgml vial of 5 ml Inj | 150 | vial | shakil.463n | 30 |
| 21 | Diazepam 10 mg 2 ml Inj | Diazepam 10 mg 2 ml Inj | 180 | amp | shakil.463n | 30 |
| 22 | Fosphenytoin 75 mgml 2ml Inj | Fosphenytoin 75 mgml 2ml Inj | 50 | amp | shakil.463n | 30 |
| 23 | Sodium Valproate 100 mgml Inj | Sodium Valproate 100 mgml Inj | 60 | vial | shakil.463n | 30 |
| 24 | Inj Amikacin IP 100 mg2 ml Vial | Inj Amikacin IP 100 mg2 ml Vial | 100 | vial | shakil.463n | 30 |
| 25 | Artesunate 60 mg Inj | Artesunate 60 mg Inj | 50 | amp | shakil.463n | 30 |
| 26 | Artemether 80 mgml 1 ml Inj | Artemether 80 mgml 1 ml Inj | 15 | amp | shakil.463n | 30 |
| 27 | Inj Ceftriaxone 500 mg Vial | Inj Ceftriaxone 500 mg Vial | 750 | vial | shakil.463n | 30 |
| 28 | Ceftriaxone 1000 mg plus Sulbactum 500 mg Inj Vial | Ceftriaxone 1000 mg plus Sulbactum 500 mg Inj Vial | 750 | vial | shakil.463n | 30 |
| 29 | Inj Cefotaxime Sodium 1000 mg plus Sulbactam 500 mg Inj Vial | Inj Cefotaxime Sodium 1000 mg plus Sulbactam 500 mg Inj Vial | 150 | vial | shakil.463n | 30 |
| 30 | Methotrexate Sodium 50mg 2 ml Inj | Methotrexate Sodium 50mg 2 ml Inj | 6 | amp | shakil.463n | 30 |
| 31 | Iron sucrose complex 20 mg in 5ml for Inj | Iron sucrose complex 20 mg in 5ml for Inj | 240 | amp | shakil.463n | 30 |
| 32 | Tranexamic Acid 500 mg5ml Inj | Tranexamic Acid 500 mg5ml Inj | 100 | amp | shakil.463n | 30 |
| 33 | Phytomenadione 1 mg0dot5 ml Vitamin K Inj | Phytomenadione 1 mg0dot5 ml Vitamin K Inj | 450 | amp | shakil.463n | 30 |
| 34 | Mannitol 20percent bottle of 100ml | Mannitol 20percent bottle of 100ml | 300 | bott | shakil.463n | 30 |
| 35 | Diltiazem 5mgml Inj | Diltiazem 5mgml Inj | 15 | vial | shakil.463n | 30 |
| 36 | Adenosine 3 mgml 2 ml Inj | Adenosine 3 mgml 2 ml Inj | 150 | amp | shakil.463n | 30 |
| 37 | Amiodarone HCl 150 mg 3 ml Inj | Amiodarone HCl 150 mg 3 ml Inj | 150 | amp | shakil.463n | 30 |
| 38 | Metoprolol 1 mgml 5 ml Inj | Metoprolol 1 mgml 5 ml Inj | 60 | amp | shakil.463n | 30 |
| 39 | Vasopressin 20 unitsml1ml Inj | Vasopressin 20 unitsml1ml Inj | 24 | amp | shakil.463n | 30 |
| 40 | Dopamine HCl 40 mgml 5ml Inj | Dopamine HCl 40 mgml 5ml Inj | 150 | amp | shakil.463n | 30 |
| 41 | Dobutamine HCl 250 mg 5 ml Inj | Dobutamine HCl 250 mg 5 ml Inj | 120 | amp | shakil.463n | 30 |
| 42 | Enoxaparin 40 mg0dot4ml Inj | Enoxaparin 40 mg0dot4ml Inj | 400 | pfs | shakil.463n | 30 |
| 43 | Labetalol HCl 5mgml 4ml Inj | Labetalol HCl 5mgml 4ml Inj | 300 | amp | shakil.463n | 30 |
| 44 | Triamcinolone Acetate 10 mgml Inj | Triamcinolone Acetate 10 mgml Inj | 90 | vial | shakil.463n | 30 |
| 45 | Frusemide 20 mg 2 ml Inj | Frusemide 20 mg 2 ml Inj | 250 | amp | shakil.463n | 30 |
| 46 | Mannitol 20percent Inj bottle of 350 ml | Mannitol 20percent Inj bottle of 350 ml | 240 | bott | shakil.463n | 30 |
| 47 | Human Albumin 20percent in bott of 100ml Inj | Human Albumin 20percent in bott of 100ml Inj | 5 | bott | shakil.463n | 30 |
| 48 | Metoclopramide HCl 5mgml 2ml Inj | Metoclopramide HCl 5mgml 2ml Inj | 100 | amp | shakil.463n | 30 |
| 49 | Dicyclomine HCl 20 mg Inj | Dicyclomine HCl 20 mg Inj | 350 | amp | shakil.463n | 30 |
| 50 | Hydroxyprogesterone Caproate 500 mg2 ml 2 ml Inj | Hydroxyprogesterone Caproate 500 mg2 ml 2 ml Inj | 450 | amp | shakil.463n | 30 |
| 51 | Isoxsuprine HCl 5mgml amp of 2 ml | Isoxsuprine HCl 5mgml amp of 2 ml | 30 | vial | shakil.463n | 30 |
| 52 | Methylergometrine maleate 0dot2mg 1 ml Inj | Methylergometrine maleate 0dot2mg 1 ml Inj | 50 | amp | shakil.463n | 30 |
| 53 | Oxytocin 5 units per 1dot0 ml amp Inj | Oxytocin 5 units per 1dot0 ml amp Inj | 900 | vial | shakil.463n | 30 |
| 54 | Magnesium sulphate 50percent wv Inj | Magnesium sulphate 50percent wv Inj | 180 | amp | shakil.463n | 30 |
| 55 | Human Chorionic Gonadotrophin 2000 IU HCG Inj | Human Chorionic Gonadotrophin 2000 IU HCG Inj | 30 | amp | shakil.463n | 30 |
| 56 | Glycopyrrolate 0dot2 mgml 1ml Inj | Glycopyrrolate 0dot2 mgml 1ml Inj | 210 | amp | shakil.463n | 30 |
| 57 | Neostigmine 0dot5 mg1 ml Inj | Neostigmine 0dot5 mg1 ml Inj | 240 | amp | shakil.463n | 30 |
| 58 | Succinylchloline Chloride 50 mgml 2 ml Inj | Succinylchloline Chloride 50 mgml 2 ml Inj | 30 | amp | shakil.463n | 30 |
| 59 | Vecuronium Bromide 4mgml 1 ml Inj | Vecuronium Bromide 4mgml 1 ml Inj | 105 | amp | shakil.463n | 30 |
| 60 | Etophylline BP 84dot7 mg and Theophylline IP | Etophylline BP 84dot7 mg and Theophylline IP | 300 | amp | shakil.463n | 30 |
| 61 | Dextrose 50percent 25 ml Inj | Dextrose 50percent 25 ml Inj | 150 | amp | shakil.463n | 30 |
| 62 | Dextrose Inj 25percent 25 ml Inj | Dextrose Inj 25percent 25 ml Inj | 150 | amp | shakil.463n | 30 |
| 63 | Meropenem 1 gm Inj | Meropenem 1 gm Inj | 420 | vial | shakil.463n | 30 |
| 64 | Multi Vit IV 2-10 ml with minimum constituents having Thiamine | Multi Vit IV 2-10 ml with minimum constituents having Thiamine | 900 | amp | shakil.463n | 30 |
| 65 | Human Insulin Analogue Glargine Recombinant DNA origin | Human Insulin Analogue Glargine Recombinant DNA origin | 500 | pfs | shakil.463n | 30 |
| 66 | Amoxycillin 1g plus Clavulanic Acid 200 mg | Amoxycillin 1g plus Clavulanic Acid 200 mg | 1,500 | vial | shakil.463n | 30 |
| 67 | Amikacin Sulphate 250 mg2 ml Inj | Amikacin Sulphate 250 mg2 ml Inj | 1,200 | vial | shakil.463n | 30 |
| 68 | Cefotaxime Sodium 1gm Inj | Cefotaxime Sodium 1gm Inj | 2,400 | vial | shakil.463n | 30 |
| 69 | Cefoperazone Sodium 1gm sulbactum | Cefoperazone Sodium 1gm sulbactum | 510 | vial | shakil.463n | 30 |
| 70 | Ceftriaxone 1 gm Monocef Inj | Ceftriaxone 1 gm Monocef Inj | 5,400 | vial | shakil.463n | 30 |
| 71 | Gentamycin sulphate Inj IMIV 40mgml 2 ml Inj | Gentamycin sulphate Inj IMIV 40mgml 2 ml Inj | 210 | vial | shakil.463n | 30 |
| 72 | Piperacillin 4 gm plusTazobactam 500 mg lyophilized Inj | Piperacillin 4 gm plusTazobactam 500 mg lyophilized Inj | 200 | vial | shakil.463n | 30 |
| 73 | Meropenem 500 mg Inj | Meropenem 500 mg Inj | 300 | vial | shakil.463n | 30 |
| 74 | Linezolid 2 mgml 300 ml Inj | Linezolid 2 mgml 300 ml Inj | 450 | bottle | shakil.463n | 30 |
| 75 | Inj Thiamine 100 mgml 2 ml Amp | Inj Thiamine 100 mgml 2 ml Amp | 150 | amp | shakil.463n | 30 |
| 76 | Tetanus Toxoid purified absorbedr | Tetanus Toxoid purified absorbedr | 500 | vial | shakil.463n | 30 |
| 77 | Dexmedetomidine 100 mcg ml vial of 50 ml Inj | Dexmedetomidine 100 mcg ml vial of 50 ml Inj | 45 | amp | shakil.463n | 30 |
| 78 | Pralidoxime 500 mg20 ml Inj | Pralidoxime 500 mg20 ml Inj | 10 | no | shakil.463n | 30 |
| 79 | Drotaverin 40mg2ml Injection | Drotaverin 40mg2ml Injection | 30 | amp | shakil.463n | 30 |
| 80 | Valethamate bromide 2 ml Inj | Valethamate bromide 2 ml Inj | 300 | amp | shakil.463n | 30 |
| 81 | Lignocaine 2percent PF Preservation Free Inj | Lignocaine 2percent PF Preservation Free Inj | 81 | vial | shakil.463n | 30 |
| 82 | Lignocaine hcl Sol 2percent for IV use 30ml Inj | Lignocaine hcl Sol 2percent for IV use 30ml Inj | 33 | vial | shakil.463n | 30 |
| 83 | Tuberculin PPD Inj | Tuberculin PPD Inj | 3 | vial | shakil.463n | 30 |
| 84 | Chloecalcifero Vitamin D3 6 Lac Inj | Chloecalcifero Vitamin D3 6 Lac Inj | 60 | amp | shakil.463n | 30 |
| 85 | Menotropin for Sodium Chloride 75 IU HMG Inj | Menotropin for Sodium Chloride 75 IU HMG Inj | 20 | vial | shakil.463n | 30 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
26-Jul-2025, 1:00 pm
End
28-Jul-2025, 2:02 pm
Duration: 50 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 16-07-2025 18:56:48 | Evaluated |
| 2 | ********** Under PMA | - | 11-07-2025 18:15:23 | Evaluated |
| 3 | ********** Under PMA | - | 15-07-2025 19:32:38 | Evaluated |
| 4 | ********** Under PMA | - | 17-07-2025 12:56:06 | Evaluated |
| 5 | ********** Under PMA | - | 16-07-2025 19:34:26 | Evaluated |
| 6 | ********** Under PMA | - | 14-07-2025 13:08:50 | Evaluated |
| 7 | ********** Under PMA | - | 16-07-2025 19:07:20 | Evaluated |
| 8 | ********** Under PMA | - | 11-07-2025 11:27:31 | Evaluated |
| 9 | ********** Under PMA | - | 17-07-2025 00:28:29 | Evaluated |
| 10 | ********** Under PMA | - | 16-07-2025 22:49:33 | Evaluated |
| 11 | ********** Under PMA | - | 16-07-2025 08:36:58 | Evaluated |
| 12 | ********** Under PMA | - | 17-07-2025 09:18:31 | Evaluated |
| 13 | ********** Under PMA | - | 16-07-2025 22:11:05 | Evaluated |
Key insights about MAHARASHTRA tender market
The eligibility requirements for this tender include being a registered entity with the necessary licenses to handle pharmaceutical products. Companies must demonstrate previous experience in supplying injectable medications to public sector healthcare or hold relevant certifications that align with industry regulations.
Bidders must submit a valid certificate of registration, along with quality assurance certificates such as ISO or equivalent. Documentation proving compliance with pharmaceutical regulations is also required to ensure that all products meet the specified quality standards.
The registration process involves creating an account on the government e-marketplace (GEM) portal, completing the necessary profile documentation, and submitting all relevant certificates as stipulated in the tender guidelines. An EMD submission is also a prerequisite for bid consideration.
Document submissions must be made electronically in formats such as PDF, JPG, or DOCX. Bidders are advised to refer to the tender instructions for any specific formatting guidelines to ensure all submitted documents are compliant.
MSEs participating in this tender may be eligible for special concessions such as reduced financial bid criteria, exemptions from EMD, and enhanced evaluation scoring. This initiative aligns with the government's objective of fostering growth and competitiveness among smaller enterprises within the pharmaceutical sector.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS